SVRA
NASDAQ · Biotechnology
Savara Inc
$4.96
-0.20 (-3.88%)
Financial Highlights (FY 2025)
Revenue
135.25M
Net Income
19.67M
Gross Margin
42.2%
Profit Margin
14.5%
Rev Growth
+10.1%
D/E Ratio
0.38
Revenue & Net Income
Margin Trends
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Gross Margin | 42.2% | 42.2% | 42.2% |
| Operating Margin | 17.6% | 17.4% | 16.2% |
| Profit Margin | 14.5% | 10.9% | 12.6% |
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 135.25M | 127.87M | 115.53M |
| Gross Profit | 57.10M | 53.99M | 48.77M |
| Operating Income | 23.76M | 22.22M | 18.69M |
| Net Income | 19.67M | 13.91M | 14.59M |
| Gross Margin | 42.2% | 42.2% | 42.2% |
| Operating Margin | 17.6% | 17.4% | 16.2% |
| Profit Margin | 14.5% | 10.9% | 12.6% |
| Rev Growth | +10.1% | -5.7% | +15.6% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 259.00M | 309.68M | 318.59M |
| Total Equity | 684.41M | 677.59M | 605.99M |
| D/E Ratio | 0.38 | 0.46 | 0.53 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 27.67M | 31.26M | 23.85M |
| Free Cash Flow | 12.49M | 17.00M | 15.12M |